Search Results - "Greig, Iain R"

Refine Results
  1. 1
  2. 2

    Genomic and non-genomic pathways are both crucial for peak induction of neurite outgrowth by retinoids by Khatib, Thabat, Marini, Pietro, Nunna, Sudheer, Chisholm, David R, Whiting, Andrew, Redfern, Christopher, Greig, Iain R, McCaffery, Peter

    Published in Cell communication and signaling (02-05-2019)
    “…Retinoic acid (RA) is the active metabolite of vitamin A and essential for many physiological processes, particularly the induction of cell differentiation. In…”
    Get full text
    Journal Article
  3. 3

    Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors by Ralston, Stuart H, Idris, Aymen I, van 't Hof, Robert J, Greig, Iain R, Ridge, Susan A, Baker, David, Ross, Ruth A

    Published in Nature medicine (01-07-2005)
    “…Accelerated osteoclastic bone resorption has a central role in the pathogenesis of osteoporosis and other bone diseases. Identifying the molecular pathways…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia by Wat, Jovian M, Hawrylyshyn, Krista, Baczyk, Dora, Greig, Iain R, Kingdom, John C

    Published in Biology of reproduction (01-11-2018)
    “…Low molecular weight heparin (LMWH) is being investigated as a potential preventative therapy against preeclampsia. There is evidence suggesting that LMWH may…”
    Get full text
    Journal Article
  6. 6

    Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids by Anavi-Goffer, Sharon, Baillie, Gemma, Irving, Andrew J., Gertsch, Jürg, Greig, Iain R., Pertwee, Roger G., Ross, Ruth A.

    Published in The Journal of biological chemistry (02-01-2012)
    “…GPR55 is activated by l-α-lysophosphatidylinositol (LPI) but also by certain cannabinoids. In this study, we investigated the GPR55 pharmacology of various…”
    Get full text
    Journal Article
  7. 7

    Motor-like Tics are Mediated by CB2 Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex by Gorberg, Victoria, Borisov, Veronika, Greig, Iain R., Pertwee, Roger G., McCaffery, Peter, Anavi-Goffer, Sharon

    Published in Molecular neurobiology (01-08-2022)
    “…Δ 9 -Tetrahydrocannabinol (Δ 9 -THC) inhibits tics in individuals with Tourette syndrome (TS). Δ 9 -THC has similar affinities for CB 1 /CB 2 cannabinoid…”
    Get full text
    Journal Article
  8. 8

    Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators by Greig, Iain R., Baillie, Gemma L., Abdelrahman, Mostafa, Trembleau, Laurent, Ross, Ruth A.

    Published in Bioorganic & medicinal chemistry letters (15-09-2016)
    “…[Display omitted] Existing CB1 negative allosteric modulators (NAMs) fall into a limited range of structural classes. In spite of the theoretical potential of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro by Idris, Aymen I., Rojas, Javier, Greig, Iain R., van’t Hof, Rob J., Ralston, Stuart H.

    Published in Calcified tissue international (01-03-2008)
    “…Bisphosphonates are widely used for the treatment of bone diseases associated with increased osteoclastic bone resorption. Bisphosphonates are known to inhibit…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy by Tseng, Chih-Chung, Noordali, Hannah, Sani, Monica, Madhani, Melanie, Grant, Denis M, Frenneaux, Michael P, Zanda, Matteo, Greig, Iain R

    Published in Journal of medicinal chemistry (13-04-2017)
    “…We designed and synthesized perhexiline analogues that have the same therapeutic profile as the parent cardiovascular drug but lacking its metabolic liability…”
    Get full text
    Journal Article
  13. 13

    In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569 by Gamage, Thomas F, Ignatowska-Jankowska, Bogna M, Wiley, Jenny L, Abdelrahman, Mostafa, Trembleau, Laurent, Greig, Iain R, Thakur, Ganesh A, Tichkule, Ritesh, Poklis, Justin, Ross, Ruth A, Pertwee, Roger G, Lichtman, Aron H

    Published in Behavioural pharmacology (01-04-2014)
    “…Several allosteric modulators (AMs) of the CB1 receptor have been characterized in vitro, including Org27569, which enhances CB1-specific binding of…”
    Get full text
    Journal Article
  14. 14

    Synthesis and structure-activity relationship studies of novel tubulysin U analogues--effect on cytotoxicity of structural variations in the tubuvaline fragment by Shankar, Sreejith P, Jagodzinska, Monika, Malpezzi, Luciana, Lazzari, Paolo, Manca, Ilaria, Greig, Iain R, Sani, Monica, Zanda, Matteo

    Published in Organic & biomolecular chemistry (14-04-2013)
    “…Tubulysins are cytotoxic natural products with promising anti-cancer properties, originally isolated from myxobacterial cultures. Structurally, tubulysins are…”
    Get more information
    Journal Article
  15. 15
  16. 16

    In Vitro Characterization of 6‑Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl‑1H‑indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator? by Green, Hayley M., Finlay, David B., Ross, Ruth A., Greig, Iain R., Duffull, Stephen B., Glass, Michelle

    Published in ACS pharmacology & translational science (09-12-2022)
    “…Orthosteric activation of CB1 is known to cause a plethora of adverse side effects in vivo. Allosteric modulation is an exciting therapeutic approach and is…”
    Get full text
    Journal Article
  17. 17

    Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in mice by Coste, Emmanuel, Greig, Iain R, Mollat, Patrick, Rose, Lorraine, Gray, Mohini, Ralston, Stuart H, van 't Hof, Rob J

    Published in Annals of the rheumatic diseases (01-01-2015)
    “…Inflammatory joint diseases such as rheumatoid arthritis are associated with local bone erosions and systemic bone loss, mediated by increased osteoclastic…”
    Get more information
    Journal Article
  18. 18

    Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis by Zhai, Dongxu, Yan, Shuxin, Samsom, James, Wang, Le, Su, Ping, Jiang, Anlong, Zhang, Haorui, Jia, Zhengping, Wallach, Izhar, Heifets, Abraham, Zanato, Chiara, Tseng, Chih-Chung, Wong, Albert H C, Greig, Iain R, Liu, Fang

    Published in Science advances (08-12-2023)
    “…While most research and treatments for multiple sclerosis (MS) focus on autoimmune reactions causing demyelination, it is possible that neurodegeneration…”
    Get full text
    Journal Article
  19. 19

    In Vitro Characterization of 6-Methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1 H -indole (ZCZ011) at the Type 1 Cannabinoid Receptor: Allosteric Agonist or Allosteric Modulator? by Green, Hayley M, Finlay, David B, Ross, Ruth A, Greig, Iain R, Duffull, Stephen B, Glass, Michelle

    Published in ACS pharmacology & translational science (09-12-2022)
    “…Orthosteric activation of CB is known to cause a plethora of adverse side effects . Allosteric modulation is an exciting therapeutic approach and is hoped to…”
    Get full text
    Journal Article
  20. 20